candesartan cilexetil has been researched along with icatibant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demura, H; Hagiwara, H; Hirose, S; Kuen, LS; Muraki, T; Naruse, K; Naruse, M; Seki, T; Shionoya, K; Tanaka, M; Yoshimoto, T | 1 |
| Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I | 1 |
2 other study(ies) available for candesartan cilexetil and icatibant
| Article | Year |
|---|---|
Angiotensin converting enzyme inhibitor normalizes vascular natriuretic peptide type A receptor gene expression via bradykinin-dependent mechanism in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Gene Expression; Indans; Rats; Rats, Inbred SHR; Receptor, Bradykinin B2; Receptors, Atrial Natriuretic Factor; Tetrazoles | 1996 |
Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Child; Diet; Fructose; Glucose; Glucose Intolerance; Humans; Hyperinsulinism; Hypertension; Insulin Resistance; Male; Rats; Rats, Wistar; Tetrazoles | 1996 |